Valuation: Rapid Dose Therapeutics Corp.

Market Cap 15.01M 10.58M 9.25M 8.49M 7.92M 1.01B 15.26M 102M 39.61M 494M 39.73M 38.86M 1.7B P/E 2025
-3.92x
P/E 2026 -5.88x
Enterprise Value 20.32M 14.32M 12.52M 11.49M 10.72M 1.36B 20.66M 138M 53.63M 669M 53.78M 52.61M 2.3B EV / Sales 2025
11.8x
EV / Sales 2026 9.23x
Free-Float
84.78%
Yield 2025 *
-
Yield 2026 -
1 day+488.03%
1 week+487.88%
Current month+487.88%
1 month-0.13%
3 months-13.78%
6 months-13.78%
Current year-13.78%
1 week 0.08
Extreme 0.0776
0.08
1 month 0.01
Extreme 0.0132
0.08
Current year 0.01
Extreme 0.0132
0.12
1 year 0.01
Extreme 0.006
0.15
3 years 0
Extreme 0.0021
0.39
5 years 0
Extreme 0.0004
1.11
10 years 0
Extreme 0
1.11
Manager TitleAgeSince
Chief Executive Officer - 02/05/2017
Director of Finance/CFO - 27/02/2020
Corporate Officer/Principal - 05/12/2019
Director TitleAgeSince
Director/Board Member - 13/04/2023
Director/Board Member - 12/08/2020
Director/Board Member 65 01/08/2023
Change 5-day change 1-year change 3-year change Capi.($)
+488.03%+487.88% - - 10.58M
+0.34%-2.07%+13.11%-54.64% 111M
0.00%+4.46%-29.17%-68.61% 89.15M
-0.98%-3.01%+60.63%+4.72% 68.57M
Average +121.73%+0.78%+14.86%-39.51% 89.71M
Weighted average by Cap. +18.21%+0.63%+11.22%-44.14%

Financials

2025 2026
Net sales 2.09M 1.47M 1.28M 1.18M 1.1M 140M 2.12M 14.2M 5.5M 68.64M 5.52M 5.4M 237M 2.77M 1.96M 1.71M 1.57M 1.46M 186M 2.82M 18.89M 7.32M 91.29M 7.34M 7.18M 315M
Net income -5.4M -3.81M -3.33M -3.06M -2.85M -363M -5.5M -36.81M -14.26M -178M -14.3M -13.99M -613M -3.39M -2.39M -2.09M -1.92M -1.79M -227M -3.45M -23.09M -8.95M -112M -8.97M -8.78M -384M
Net Debt 2.59M 1.83M 1.59M 1.46M 1.37M 174M 2.63M 17.63M 6.83M 85.22M 6.85M 6.7M 294M 5.31M 3.74M 3.27M 3M 2.8M 356M 5.4M 36.16M 14.01M 175M 14.05M 13.75M 602M
Logo Rapid Dose Therapeutics Corp.
Rapid Dose Therapeutics Corp. is a Canadian biotechnology company. It provides disruptive drug delivery technologies designed to improve patient outcomes. Its flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient. It has one operating segment comprising production, distribution, research, and the provision of technical services for the delivery of oral thin film strips containing active ingredients. It offers over-the-counter and pharmaceutical drug delivery solutions. Its QuickStrip Energy delivers energizing caffeine. Its QuickStrip B12 delivers vitamin B12 to the system, assisting with metabolism and physical energy. Its QuickStrip Sleep delivers melatonin to the system, inducing natural and healthy sleep. QuickStrip Lidocaine is its dental product.
Employees
-
Date Price Change Volume